IRCT20180620040164N40尚未招募未知
Comparative bioequivalence study of Desloratadine 5 mg Tablet of . and Aerius of Merk as reference in 24 healthy male under fasting.
Darou darman Pars Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 45 years(—)
- 性别
- Male
入选标准
- •Healthy subjects (male) between 20 – 45 years of age and Body Mass Index (BMI) within 15% of normal range according to the accepted normal values between 18.5 and 30 (inclusive), calculated as kg/m2.
- •Subjects with no significant diseases or clinically significant abnormal findings during screening, medical history, clinical examination and laboratory evaluations.
- •Subjects with normal vital signs.
- •Subjects who agree with patient consent form.
排除标准
- •Subjects with known allergy to the products tested.
- •Smoking more than 10 cigarettes per day and could not tolerate cigarette cessation during each clinical period.
- •Subjects who has used any prescription or OTC drugs 14 days prior to the initiation of study and unable to refrain from the concomitant medications.
- •History of alcohol or drug abuse.
- •Heavy drinker of caffeine, grapefruit juice or caffeinated drinks or who are on special diet (such as vegetarians) or do exertional physical activity.
- •A history of difficulty with donating blood or donation of more than 500 ml blood within 7 days prior to the start of the study.
研究者
相似试验
尚未招募
Unknown
Comparative in vivo evaluation of 2 Desloratadine 5 mg Tablet formulations.IRCT20180620040164N60Actover Pharmaceutical Co.24
尚未招募
Unknown
Comparative in vivo evaluation of 2 Desloratadine 5 mg Tablet formulations.IRCT20180620040164N61Darou darman Arang24
已完成
Unknown
Bioequivalence Study of desloratadine 5 mg manufactured by Pharma Chemi and Clarinex manufactured by ScheringIRCT20220209053979N7Pharmachemi Company24
尚未招募
不适用
Study of absorption and elimination rate of Desloratadine 5-mg tablets in comparison with Desloratadine brand tablets (Clarinex®).IRCT20200407046981N50Behestan Pharmaceutical Company24
进行中(未招募)
不适用
Combined treatment of cinnarizine and iprazochrome in urticaria factitiaEUCTR2012-004002-10-HUDepartment of Dermatology and Allergology, University of Szeged
